Cargando…
Contemporary Mouse Models in Glioma Research
Despite advances in understanding of the molecular pathogenesis of glioma, outcomes remain dismal. Developing successful treatments for glioma requires faithful in vivo disease modeling and rigorous preclinical testing. Murine models, including xenograft, syngeneic, and genetically engineered models...
Autores principales: | Hicks, William H., Bird, Cylaina E., Traylor, Jeffrey I., Shi, Diana D., El Ahmadieh, Tarek Y., Richardson, Timothy E., McBrayer, Samuel K., Abdullah, Kalil G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004772/ https://www.ncbi.nlm.nih.gov/pubmed/33806933 http://dx.doi.org/10.3390/cells10030712 |
Ejemplares similares
-
Patient-Derived Cancer Organoids for Precision Oncology Treatment
por: Pernik, Mark N., et al.
Publicado: (2021) -
Molecular and Metabolic Mechanisms Underlying Selective 5-Aminolevulinic Acid-Induced Fluorescence in Gliomas
por: Traylor, Jeffrey I., et al.
Publicado: (2021) -
Semi-Automated Computational Assessment of Cancer Organoid Viability Using Rapid Live-Cell Microscopy
por: Buehler, Joseph D, et al.
Publicado: (2022) -
Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023) -
Establishment of patient-derived organoid models of lower-grade glioma
por: Abdullah, Kalil G, et al.
Publicado: (2021)